These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1450046)

  • 21. Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
    Kelly K; Crowley JJ; Bunn PA; Hazuka MB; Beasley K; Upchurch C; Weiss GR; Hicks WJ; Gandara DR; Rivkin S
    J Clin Oncol; 1995 Dec; 13(12):2924-30. PubMed ID: 8523056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.
    Oberg K; Eriksson B; Janson ET
    Digestion; 1994; 55 Suppl 3():64-9. PubMed ID: 7698540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized phase II trial of either fluorouracil, parenteral hydroxyurea, interferon-alpha-2a, and filgrastim or doxorubicin/docetaxel in patients with advanced gastric cancer with quality-of-life assessment: eastern cooperative oncology group study E6296.
    Wadler S; Brain C; Catalano P; Einzig AI; Cella D; Benson AB
    Cancer J; 2002; 8(3):282-6. PubMed ID: 12074329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma.
    Purohit A; Moreau L; Dietemann A; Seibert R; Pauli G; Wihlm JM; Quoix E
    Lung Cancer; 1998 Nov; 22(2):119-25. PubMed ID: 10022219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
    Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
    Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of vinblastine and doxorubicin with interferon alpha.
    Jekunen A; Pyrhönen S
    Am J Clin Oncol; 1996 Aug; 19(4):384-5. PubMed ID: 8677910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanoma.
    Eton O; Talpaz M; Lee KH; Rothberg JM; Brell JM; Benjamin RS
    Cancer; 1996 Mar; 77(5):893-9. PubMed ID: 8608480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.
    Yao JC; Phan A; Hoff PM; Chen HX; Charnsangavej C; Yeung SC; Hess K; Ng C; Abbruzzese JL; Ajani JA
    J Clin Oncol; 2008 Mar; 26(8):1316-23. PubMed ID: 18323556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
    Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
    J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group.
    De Mulder PH; Oosterhof G; Bouffioux C; van Oosterom AT; Vermeylen K; Sylvester R
    Br J Cancer; 1995 Feb; 71(2):371-5. PubMed ID: 7841054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.
    Bajetta E; Zilembo N; Di Bartolomeo M; Di Leo A; Pilotti S; Bochicchio AM; Castellani R; Buzzoni R; Celio L; Dogliotti L
    Cancer; 1993 Nov; 72(10):3099-105. PubMed ID: 7693327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.
    Yao G; Ji Y; Yang M; Xu D; Gao J; Wu X; Zhang Q; Hu D
    Chin Med J (Engl); 1998 Oct; 111(10):922-6. PubMed ID: 11189241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
    Oken MM; Kyle RA; Greipp PR; Kay NE; Tsiatis A; Gregory SA; Spiegel R J; O'Connell M J
    Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study.
    Dorval T; Négrier S; Chevreau C; Avril MF; Baume D; Cupissol D; Oskam R; de Peuter R; Vinke J; Herrera A; Escudier B
    Cancer; 1999 Mar; 85(5):1060-6. PubMed ID: 10091789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer.
    Sparano JA; Wadler S; Liebes L; Robert NJ; Schwartz EL; Dutcher JP
    Cancer Res; 1993 Aug; 53(15):3509-12. PubMed ID: 8339255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study.
    Fosså SD; Martinelli G; Otto U; Schneider G; Wander H; Oberling F; Bauer HW; Achtnicht U; Holdener EE
    Ann Oncol; 1992 Apr; 3(4):301-5. PubMed ID: 1390305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon.
    Oberg K; Norheim I; Alm G
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1475-9. PubMed ID: 2480243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-fluorouracil and low-dose recombinant interferon-alpha-2a in patients with hormone-refractory adenocarcinoma of the prostate.
    Shinohara N; Demura T; Matsumura K; Toyoda K; Kashiwagi A; Nagamori S; Ohmuro H; Ohzono S; Koyanagi T
    Prostate; 1998 Apr; 35(1):56-62. PubMed ID: 9537600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced malignant melanoma with recombinant interferon alfa-2a in combination with DTIC: long-term follow-up of two phase II studies.
    Hersey P; McLeod GR; Thomson DB
    Br J Haematol; 1991 Oct; 79 Suppl 1():60-6. PubMed ID: 1931712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.